Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether his Department plans to hold discussions with representatives of people with (a) cystic fibrosis and (b) other people likely to be disproportionately affected by antimicrobial resistance on the development of the next five-year antimicrobial resistance action plan.

On 23 November 2022, we launched a call for evidence to inform the development of the national action plan for anti-microbial resistance for 2024 to 2029. The call for evidence is aimed at stakeholders, including patient groups and representatives and will be open until 20 January 2023. In addition to the call for evidence, the national action plan will be developed in consultation with a range of stakeholders and we are considering how we can engage with patient representatives and interest groups.